Related Experiment Video
Updated: Jun 8, 2026

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
Factor XIII: novel structural and functional aspects
I Komáromi1, Z Bagoly, L Muszbek
1Clinical Research Center Thrombosis, Haemostasis and Vascular Biology Research Group of the Hungarian Academy of Sciences, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary.
Factor XIII (FXIII) is a crucial enzyme for hemostasis and cellular functions. Its structure and activation mechanisms, particularly the role of FXIII-A and FXIII-B subunits, are key to understanding its diverse biological roles.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Factor XIII (FXIII) is a protransglutaminase essential for hemostasis and possesses diverse intracellular functions.
- Plasmatic FXIII (pFXIII) is a tetramer (FXIII-A2B2), while cellular FXIII (cFXIII) is a dimer (FXIII-A2).
- FXIII-A shares conserved structural domains with other transglutaminases, while FXIII-B is a glycoprotein composed of sushi domains.
Purpose of the Study:
- To elucidate the structural elements of FXIII-A involved in FXIII-B interaction.
- To review the activation process of pFXIII and cFXIII.
- To present a molecular model of FXIIIa structure and discuss its implications for enzyme activity.
Main Methods:
- Literature review and analysis of structural and biochemical studies.
- Molecular modeling based on analogies with transglutaminase-2.
- Biochemical studies to validate structural models.
Main Results:
- The first sushi domain of FXIII-B appears critical for complex formation with FXIII-A.
- pFXIII activation involves thrombin cleavage, Ca(2+) -dependent dissociation of FXIII-B, and fibrinogen acceleration.
- cFXIII activation bypasses proteolysis.
- A molecular model of FXIIIa structure was developed, aligning with biochemical findings.
Conclusions:
- Understanding FXIII structure-function relationships is vital for its roles in hemostasis and cellular processes.
- The molecular model provides insights into FXIIIa's active conformation and substrate interactions.
- Further research into FXIII's structural dynamics can illuminate its therapeutic potential.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

